Warning: The NCBI web site requires JavaScript to function. more...
Understanding the pharmacokinetics of Coartem.
Djimdé A, Lefèvre G.
Malar J. 2009 Oct 12;8 Suppl 1:S4. Review.
Related citations
The effect of food consumption on lumefantrine bioavailability in African children receiving artemether-lumefantrine crushed or dispersible tablets (Coartem) for acute uncomplicated Plasmodium falciparum malaria.
Borrmann S, Sallas WM, Machevo S, González R, Björkman A, Mårtensson A, Hamel M, Juma E, Peshu J, Ogutu B, Djimdé A, D'Alessandro U, Marrast AC, Lefèvre G, Kern SE.
Trop Med Int Health. 2010 Apr;15(4):434-41. Epub 2010 Feb 17.
Pharmacokinetics and electrocardiographic pharmacodynamics of artemether-lumefantrine (Riamet) with concomitant administration of ketoconazole in healthy subjects.
Lefèvre G, Carpenter P, Souppart C, Schmidli H, McClean M, Stypinski D.
Br J Clin Pharmacol. 2002 Nov;54(5):485-92.
The pharmacokinetics of artemether and lumefantrine in pregnant women with uncomplicated falciparum malaria.
McGready R, Stepniewska K, Lindegardh N, Ashley EA, La Y, Singhasivanon P, White NJ, Nosten F.
Eur J Clin Pharmacol. 2006 Dec;62(12):1021-31. Epub 2006 Oct 20. Erratum in: Eur J Clin Pharmacol. 2009 Aug;65(8):847.
Coartem: the journey to the clinic.
Premji ZG.
Malar J. 2009 Oct 12;8 Suppl 1:S3. Review.
Pharmacokinetic and pharmacodynamic characteristics of a new pediatric formulation of artemether-lumefantrine in African children with uncomplicated Plasmodium falciparum malaria.
Djimdé AA, Tekete M, Abdulla S, Lyimo J, Bassat Q, Mandomando I, Lefèvre G, Borrmann S; B2303 Study Group.
Antimicrob Agents Chemother. 2011 Sep;55(9):3994-9. Epub 2011 Jun 13.
A randomized, open-label, comparative efficacy trial of artemether-lumefantrine suspension versus artemether-lumefantrine tablets for treatment of uncomplicated Plasmodium falciparum malaria in children in western Kenya.
Juma EA, Obonyo CO, Akhwale WS, Ogutu BR.
Malar J. 2008 Dec 22;7:262.
Clinical pharmacokinetics and pharmacodynamics and pharmacodynamics of artemether-lumefantrine.
White NJ, van Vugt M, Ezzet F.
Clin Pharmacokinet. 1999 Aug;37(2):105-25. Review.
Pharmacokinetic study of artemether-lumefantrine given once daily for the treatment of uncomplicated multidrug-resistant falciparum malaria.
Ashley EA, Stepniewska K, Lindegårdh N, McGready R, Annerberg A, Hutagalung R, Singtoroj T, Hla G, Brockman A, Proux S, Wilahphaingern J, Singhasivanon P, White NJ, Nosten F.
Trop Med Int Health. 2007 Feb;12(2):201-8.
Population pharmacokinetics and therapeutic response of CGP 56697 (artemether + benflumetol) in malaria patients.
Ezzet F, Mull R, Karbwang J.
Br J Clin Pharmacol. 1998 Dec;46(6):553-61.
Population pharmacokinetics and pharmacodynamics of artemether and lumefantrine during combination treatment in children with uncomplicated falciparum malaria in Tanzania.
Hietala SF, Mårtensson A, Ngasala B, Dahlström S, Lindegårdh N, Annerberg A, Premji Z, Färnert A, Gil P, Björkman A, Ashton M.
Antimicrob Agents Chemother. 2010 Nov;54(11):4780-8. Epub 2010 Aug 16.
A clinical and pharmacokinetic trial of six doses of artemether-lumefantrine for multidrug-resistant Plasmodium falciparum malaria in Thailand.
Lefèvre G, Looareesuwan S, Treeprasertsuk S, Krudsood S, Silachamroon U, Gathmann I, Mull R, Bakshi R.
Am J Trop Med Hyg. 2001 May-Jun;64(5-6):247-56.
The content of African diets is adequate to achieve optimal efficacy with fixed-dose artemether-lumefantrine: a review of the evidence.
Premji ZG, Abdulla S, Ogutu B, Ndong A, Falade CO, Sagara I, Mulure N, Nwaiwu O, Kokwaro G.
Malar J. 2008 Nov 25;7:244. Review.
Interaction trial between artemether-lumefantrine (Riamet) and quinine in healthy subjects.
Lefèvre G, Carpenter P, Souppart C, Schmidli H, Martin JM, Lane A, Ward C, Amakye D.
J Clin Pharmacol. 2002 Oct;42(10):1147-58.
Lopinavir/ritonavir affects pharmacokinetic exposure of artemether/lumefantrine in HIV-uninfected healthy volunteers.
German P, Parikh S, Lawrence J, Dorsey G, Rosenthal PJ, Havlir D, Charlebois E, Hanpithakpong W, Lindegardh N, Aweeka FT.
J Acquir Immune Defic Syndr. 2009 Aug 1;51(4):424-9.
Early clinical development of artemether-lumefantrine dispersible tablet: palatability of three flavours and bioavailability in healthy subjects.
Abdulla S, Amuri B, Kabanywanyi AM, Ubben D, Reynolds C, Pascoe S, Fitoussi S, Yeh CM, Nuortti M, Séchaud R, Kaiser G, Lefèvre G.
Malar J. 2010 Sep 3;9:253.
Dispersible formulation of artemether/lumefantrine: specifically developed for infants and young children.
Abdulla S, Sagara I.
Malar J. 2009 Oct 12;8 Suppl 1:S7. Review.
Coartemether (artemether and lumefantrine): an oral antimalarial drug.
Wernsdorfer WH.
Expert Rev Anti Infect Ther. 2004 Apr;2(2):181-96. Review.
Pharmacokinetics of artemether and dihydroartemisinin in healthy Pakistani male volunteers treated with artemether-lumefantrine.
Ali S, Najmi MH, Tarning J, Lindegardh N.
Malar J. 2010 Oct 11;9:275.
How much fat is necessary to optimize lumefantrine oral bioavailability?
Ashley EA, Stepniewska K, Lindegårdh N, Annerberg A, Kham A, Brockman A, Singhasivanon P, White NJ, Nosten F.
Trop Med Int Health. 2007 Feb;12(2):195-200.
Filter your results:
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on